about
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents.A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis.A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.Mitoxantrone (Novantrone) in multiple sclerosis: new insights.Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
P2860
Q33644812-D7C732DC-04D8-46A9-ACFA-0BE30FCD8E45Q34714866-5202082D-8A0C-45A8-9913-AA796234AA56Q34924287-E7181EAB-8E83-46CC-94DD-28221D333DDAQ35753383-6FB2C11D-04FE-44DA-9ADF-6B7F280BD103Q35818165-C7806024-2F12-476B-8EFC-FA008A236AEFQ36107235-8DA5A8DB-0DB2-49F1-9ED2-BF1DE7CB06A2Q44344138-3EF60D13-DB10-4F3D-A2D2-EC94AD425F93Q46104696-36BA3E47-820E-441F-BA32-DF0679A2389E
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Mitoxantrone immunotherapy in multiple sclerosis.
@en
type
label
Mitoxantrone immunotherapy in multiple sclerosis.
@en
prefLabel
Mitoxantrone immunotherapy in multiple sclerosis.
@en
P2860
P1476
Mitoxantrone immunotherapy in multiple sclerosis.
@en
P2093
R E Gonsette
P2860
P304
P356
10.1177/135245859600100608
P577
1996-07-01T00:00:00Z